Literature DB >> 931786

The structure of bestatin.

H Suda, T Takita, T Aoyagi, H Umezawa.   

Abstract

Mesh：

Substances：

Year:  1976        PMID： 931786     DOI： 10.7164/antibiotics.29.100

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN： 0021-8820            Impact factor:   2.649


× No keyword cloud information.
  16 in total

1.  Leucine aminopeptidase: bestatin inhibition and a model for enzyme-catalyzed peptide hydrolysis.

Authors:  S K Burley; P R David; W N Lipscomb
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-15       Impact factor: 11.205

2.  Aminophosphinic inhibitors as transition state analogues of enkephalin-degrading enzymes: a class of central analgesics.

Authors:  H Chen; F Noble; P Coric; M C Fournie-Zaluski; B P Roques
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-29       Impact factor: 11.205

3.  Gelatin degradation assay reveals MMP-9 inhibitors and function of O-glycosylated domain.

Authors:  Jennifer Vandooren; Nathalie Geurts; Erik Martens; Philippe E Van den Steen; Steven De Jonghe; Piet Herdewijn; Ghislain Opdenakker
Journal:  World J Biol Chem       Date:  2011-01-26

4.  Distribution and biochemical properties of an M1-family aminopeptidase in Plasmodium falciparum indicate a role in vacuolar hemoglobin catabolism.

Authors:  Daniel Ragheb; Seema Dalal; Kristin M Bompiani; W Keith Ray; Michael Klemba
Journal:  J Biol Chem       Date:  2011-06-09       Impact factor: 5.157

5.  Prospective randomized controlled study on bestatin in resectable gastric cancer--third report.

Authors:  M Niimoto; T Saeki; M Toi; M Nishiyama; T Hirai; E Yanagawa; T Hattori
Journal:  Jpn J Surg       Date:  1990-03

6.  Restoration of E-rosette formation by bestatin in patients with bladder cancer.

Authors:  H Yokoyama; T Umeda; K Kobayashi; H Akaza; T Niijima
Journal:  J Cancer Res Clin Oncol       Date:  1980       Impact factor: 4.553

7.  Two cap residues in the S1 subsite of a Plasmodium falciparum M1-family aminopeptidase promote broad specificity and enhance catalysis.

Authors:  Matthew Rosati; Seema Dalal; Michael Klemba
Journal:  Mol Biochem Parasitol       Date:  2017-08-12       Impact factor: 1.759

8.  Increased angiotensin-converting enzyme in peripheral blood monocytes from patients with sarcoidosis.

Authors:  T Okabe; K Yamagata; M Fujisawa; J Watanabe; F Takaku; J J Lanzillo; B L Fanburg
Journal:  J Clin Invest       Date:  1985-03       Impact factor: 14.808

9.  Adjuvant Bestatin immunotherapy in patients with transitional cell carcinoma of the bladder. Clinical results of a randomized trial.

Authors:  H Blomgren; I Näslund; P L Esposti; L Johansen; O Aaskoven
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

10.  Chemoimmunotherapy with cyclophosphamide and bestatin in experimental metastasis in mice.

Authors:  F Abe; M Schneider; P L Black; J E Talmadge
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.